Connect With the Organizations Shaping the Future of Drug Development in Rare Neurology
Rare genetic epilepsies are rapidly becoming one of the most attractive opportunities in neuroscience drug development. As companies invest in ASOs, gene therapies, RNA medicines, precision small molecules, and other disease-modifying approaches, demand continues to grow for specialist partners capable of accelerating development, generating evidence, improving trial execution, and supporting commercialization.
The Rare Epilepsy & DEE Drug Development Summit provides direct access to senior decision-makers actively seeking innovative solutions across translational research, clinical development, biomarker strategy, patient identification, trial execution, regulatory planning, and commercialization.
What to Expect?
Showcase Your Expertise
Demonstrate how your solutions address the industry's most pressing development challenges
Engage True Decision-Makers
Connect directly with executives and leaders responsible for outsourcing, partnerships, and strategic investments
Gain Competitive Intelligence
Understand emerging trends, investment priorities, and future areas of innovation
Raise Brand Visibility
Position your organization alongside industry leaders including Biogen, Lundbeck, Ionis Pharmaceuticals, Jazz Pharmaceuticals, and GRIN Therapeutics
Generate Qualified Opportunities
Build relationships with organizations actively progressing therapies through preclinical and clinical development
Key Services & Solutions
Our highly specific audience of biopharma executives are actively seeking specialist service and solution providers in the following areas:
- Preclinical Models & Translational Research
- Human iPSC & Organoid Platforms
- Rare Disease Clinical CROs
- EEG Services & Neurophysiology Solutions
- Biomarker Development
- Regulatory & Market Access Consulting
- Patient Identification & Recruitment
- Clinical Data & Digital Endpoint Technologies
Attending Companies Include
Hear What Our Past Sponsors Have to Say
Big enough to make it worthwhile in terms of making new connections but small enough to make networking possible. Lots of nice interaction during the sessions
Jonathan Nassi, Senior Director Translational Science, Bruker
A meeting with like minded scientists who are all excited about neuropsychiatry
Alishah Suleman, Principal Investigator, Clerkenwell Health
Audience Composition
Company Type
Attendee Seniority
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Name Surname
Job Title
Event/ Topic Area Name